In-hospital adverse drug events: analysis of trend in Portuguese public hospitals

Detalhes bibliográficos
Autor(a) principal: Mavilde Vitorino
Data de Publicação: 2020
Outros Autores: Pedro Aguiar, Paulo Sousa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Cadernos de Saúde Pública
Texto Completo: https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7313
Resumo: The objectives of this study were to analyze in-hospital adverse drug events (ADEs) in Portuguese public hospitals, and their association with mortality and the duration of hospitalization. We analyzed an administrative database containing the registration of all hospitalizations occurring in Portuguese public hospitals in 2013-2015. ADEs were identified using the codes E850-858.9 and E930-949.9 from ICD-9-CM. We identified all episodes with registration of in-hospital ADE and we compared them with a random sample of an equal number of episodes with no events recorded. A total of 3,041,443 cases were analyzed, 60,521 presented at least one ADE from which 17,213 occurred in hospital context. The most frequent drug classes associated with ADE were the antineoplastics/immunosuppressant drugs, antibiotics and steroids. Patient characteristics associated with a greater occurrence of in-hospital ADEs (all with p < 0.001) were medical admissions (OR = 1.29), the diagnosis - myeloid leukaemia (OR = 18.63), nephrotic syndrome (OR = 15.75), pneumonia (OR = 1.33) -, a higher number of secondary diagnoses (OR = 1.27), and increased duration of hospital stay (OR = 1.06). Hospitalizations with records of in-hospital ADEs presented a significantly higher mortality (9.6% vs. 4.5) and duration of hospitalization (22.6 vs. 6.4 days). ADEs were shown to be directly associated with an increase in the duration of hospital stay of 8.18 days. This study adds some interesting insights related to the most frequent drug classes and patient characteristics that can influence the frequency of ADEs in Portuguese public hospitals and also the burden of injury resulting from them.
id FIOCRUZ-5_3eec6c5278299b607190ceaeabb88500
oai_identifier_str oai:ojs.teste-cadernos.ensp.fiocruz.br:article/7313
network_acronym_str FIOCRUZ-5
network_name_str Cadernos de Saúde Pública
repository_id_str
spelling In-hospital adverse drug events: analysis of trend in Portuguese public hospitalsAdverse EventInternational Classification of DiseasesHospitalizationThe objectives of this study were to analyze in-hospital adverse drug events (ADEs) in Portuguese public hospitals, and their association with mortality and the duration of hospitalization. We analyzed an administrative database containing the registration of all hospitalizations occurring in Portuguese public hospitals in 2013-2015. ADEs were identified using the codes E850-858.9 and E930-949.9 from ICD-9-CM. We identified all episodes with registration of in-hospital ADE and we compared them with a random sample of an equal number of episodes with no events recorded. A total of 3,041,443 cases were analyzed, 60,521 presented at least one ADE from which 17,213 occurred in hospital context. The most frequent drug classes associated with ADE were the antineoplastics/immunosuppressant drugs, antibiotics and steroids. Patient characteristics associated with a greater occurrence of in-hospital ADEs (all with p < 0.001) were medical admissions (OR = 1.29), the diagnosis - myeloid leukaemia (OR = 18.63), nephrotic syndrome (OR = 15.75), pneumonia (OR = 1.33) -, a higher number of secondary diagnoses (OR = 1.27), and increased duration of hospital stay (OR = 1.06). Hospitalizations with records of in-hospital ADEs presented a significantly higher mortality (9.6% vs. 4.5) and duration of hospitalization (22.6 vs. 6.4 days). ADEs were shown to be directly associated with an increase in the duration of hospital stay of 8.18 days. This study adds some interesting insights related to the most frequent drug classes and patient characteristics that can influence the frequency of ADEs in Portuguese public hospitals and also the burden of injury resulting from them.Los objetivos del estudio fueron analizar eventos adversos con medicamentos (EAMs) en hospitales públicos portugueses, así como su asociación con la mortalidad y la duración de la hospitalización. Analizamos una base de datos administrativa, que contenía el registro de todas las hospitalizaciones que se produjeron en hospitales públicos portugueses desde 2013 a 2015. Los EAMs fueron identificados usando los códigos E850-858.9 y E930-949.9 desde CIE-9-MC. Identificamos todos los episodios registrados de EAMs en hospitales y los comparamos con una muestra aleatoria de un número igual de episodios sin eventos registrados. Se analizaron un total de 3.041.443 de casos, 60.521 presentaron al menos un EAM de los 17.213 que se produjeron en un contexto hospitalario. Los tipos de medicamentos más frecuentes, asociados con EAM, fueron los antineoplásicos/inmunosupresores, antibióticos y esteroides. Las características del paciente, asociadas con una ocurrencia mayor de eventos adversos con medicamentos en hospitales, (todos con p < 0,001) fueron: admisiones médicas (OR = 1,29); diagnóstico de leucemia mieloide (OR = 18,63), síndrome nefrítico (OR = 15,75) o neumonía (OR = 1,33); un alto número de diagnósticos secundarios (OR = 1,27), así como una duración mayor en el ingreso hospitalario (OR = 1,06). Las hospitalizaciones con registros de EAMs en hospitales presentaron una mortalidad significativamente más alta (9,6% vs. 4,5), así como la duración de la hospitalización (22,6 vs. 6,4 días). Los EAMs mostraron estar directamente asociados con el incremento en los ingresos hospitalarios a partir de los 8,18 días. Este estudio añade algunos planteamientos interesantes, relacionados con los tipos de medicamentos más frecuentes y características de los pacientes, que pueden influenciar en la frecuencia de EAMs en hospitales públicos portugueses, así como también en la carga de las lesiones resultante de los mismos.O estudo teve como objetivos analisar os eventos adversos a medicamentos (EAMs) em hospitais públicos de Portugal e a associação com mortalidade hospitalar e tempo de internação. Foi analisada uma base de dados administrativos com registros de todas as internações em hospitais públicos portugueses entre 2013 e 2015. Os EAMs foram identificados com o uso dos códigos E850-858.9 e E930-949.9 da CID-9-MC. Identificamos todos os episódios com registro de EAM hospitalar e comparamos com uma amostra aleatória de um número igual de episódios, sem registro de eventos. Foram analisados 3.041.443 casos, dos quais 60.521 apresentavam pelo menos um EAM, das quais 17.213 ocorreram no contexto hospitalar. As classes de drogas mais associadas aos EAMs foram antineoplásicos/imunossupressores, antibióticos e corticosteroides. As características dos pacientes mais associadas aos EAMs (todas com p < 0,001) foram internações pela clínica médica (OR = 1,29), diagnóstico de leucemia mieloide (OR = 18,63), síndrome nefrótica (OR = 15,75) ou pneumonia (OR = 1,33), número maior de diagnósticos secundários (OR = 1,27) e maior tempo de internação (OR = 1,06). As hospitalizações com registro de EAM hospitalar mostraram mortalidade significativamente mais elevada (9,6% vs. 4,5) e maior tempo de internação (22,6 vs. 6,4 dias). Os EAMs mostraram associação direta com o tempo de internação hospitalar, aos 8,18 dias. O estudo traz contribuições interessantes relacionadas às classes farmacológicas mais frequentes e às características dos pacientes que podem influenciar a frequência de EAMs nos hospitais públicos portugueses e a consequente carga de morbidade.Reports in Public HealthCadernos de Saúde Pública2020-03-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlapplication/pdfhttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7313Reports in Public Health; Vol. 36 No. 3 (2020): MarchCadernos de Saúde Pública; v. 36 n. 3 (2020): Março1678-44640102-311Xreponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZenghttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7313/16082https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7313/16083Mavilde VitorinoPedro AguiarPaulo Sousainfo:eu-repo/semantics/openAccess2024-03-06T15:29:53Zoai:ojs.teste-cadernos.ensp.fiocruz.br:article/7313Revistahttps://cadernos.ensp.fiocruz.br/ojs/index.php/csphttps://cadernos.ensp.fiocruz.br/ojs/index.php/csp/oaicadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2024-03-06T13:08:24.706406Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)true
dc.title.none.fl_str_mv In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
title In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
spellingShingle In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
Mavilde Vitorino
Adverse Event
International Classification of Diseases
Hospitalization
title_short In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
title_full In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
title_fullStr In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
title_full_unstemmed In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
title_sort In-hospital adverse drug events: analysis of trend in Portuguese public hospitals
author Mavilde Vitorino
author_facet Mavilde Vitorino
Pedro Aguiar
Paulo Sousa
author_role author
author2 Pedro Aguiar
Paulo Sousa
author2_role author
author
dc.contributor.author.fl_str_mv Mavilde Vitorino
Pedro Aguiar
Paulo Sousa
dc.subject.por.fl_str_mv Adverse Event
International Classification of Diseases
Hospitalization
topic Adverse Event
International Classification of Diseases
Hospitalization
description The objectives of this study were to analyze in-hospital adverse drug events (ADEs) in Portuguese public hospitals, and their association with mortality and the duration of hospitalization. We analyzed an administrative database containing the registration of all hospitalizations occurring in Portuguese public hospitals in 2013-2015. ADEs were identified using the codes E850-858.9 and E930-949.9 from ICD-9-CM. We identified all episodes with registration of in-hospital ADE and we compared them with a random sample of an equal number of episodes with no events recorded. A total of 3,041,443 cases were analyzed, 60,521 presented at least one ADE from which 17,213 occurred in hospital context. The most frequent drug classes associated with ADE were the antineoplastics/immunosuppressant drugs, antibiotics and steroids. Patient characteristics associated with a greater occurrence of in-hospital ADEs (all with p < 0.001) were medical admissions (OR = 1.29), the diagnosis - myeloid leukaemia (OR = 18.63), nephrotic syndrome (OR = 15.75), pneumonia (OR = 1.33) -, a higher number of secondary diagnoses (OR = 1.27), and increased duration of hospital stay (OR = 1.06). Hospitalizations with records of in-hospital ADEs presented a significantly higher mortality (9.6% vs. 4.5) and duration of hospitalization (22.6 vs. 6.4 days). ADEs were shown to be directly associated with an increase in the duration of hospital stay of 8.18 days. This study adds some interesting insights related to the most frequent drug classes and patient characteristics that can influence the frequency of ADEs in Portuguese public hospitals and also the burden of injury resulting from them.
publishDate 2020
dc.date.none.fl_str_mv 2020-03-13
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7313
url https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7313
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7313/16082
https://cadernos.ensp.fiocruz.br/ojs/index.php/csp/article/view/7313/16083
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
application/pdf
dc.publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
publisher.none.fl_str_mv Reports in Public Health
Cadernos de Saúde Pública
dc.source.none.fl_str_mv Reports in Public Health; Vol. 36 No. 3 (2020): March
Cadernos de Saúde Pública; v. 36 n. 3 (2020): Março
1678-4464
0102-311X
reponame:Cadernos de Saúde Pública
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Cadernos de Saúde Pública
collection Cadernos de Saúde Pública
repository.name.fl_str_mv Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br
_version_ 1798943391526944768